跳至主要内容
临床试验/NL-OMON44482
NL-OMON44482撤回不适用

A randomised controlled trial comparing FECal Microbiota Transplantation after BUDesonide or placebo induction in patients with ulcerative colitis; the FECBUD trial - FMT for ulcerative colitis after initiation of budesonide

Haaglanden Medisch Centrum0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • patients > 18 years old (n<=24) with mild or moderate activity of ulcerative colitis despite previous maintenance therapy (mesalazine, or thiopurine, or anti-TNF, or vedolizumab) with a MAYO endoscopic subscore of I or II.

排除标准

  • amongst others: pregnancy, need for (continuous) antibiotic treatment, previous prednisolon or budenofalk resistant inflammation.

研究者

相似试验